Catalyst Pharmaceuticals CPRX
CPRX
$31.49 +0.00 (+0.00%)
At close: Jul 21, 2026 · 4:00 PM EDT

Catalyst Pharmaceuticals (CPRX) Liabilities and Shareholders Equity (2010 - 2026)

Updated

Catalyst Pharmaceuticals (CPRX) recorded Liabilities and Shareholders Equity of $1.15 billion in Q1 2026, up 26.3% from $908.87 million a year earlier and up 4.0% from the prior quarter.

Analysis

Catalyst Pharmaceuticals (CPRX) Liabilities and Shareholders Equity (2010 - 2026) Analysis & Trends

At the end of FY2025, Catalyst Pharmaceuticals reported Liabilities and Shareholders Equity of $1.1 billion, up 29.7% from FY2024.

  • Annual Liabilities and Shareholders Equity has increased for seven straight years, with a five-year compound annual growth rate of 41.8% (FY2020 to FY2025).
  • Across earlier years, Liabilities and Shareholders Equity came in at $851.41 million in FY2024 (+81.1%), $470.11 million in FY2023 (+25.2%), $375.63 million in FY2022 (+58.0%) and $237.79 million in FY2021 (+23.6%).
  • The Q1 2026 figure is the highest quarterly Liabilities and Shareholders Equity in data going back to Q4 2010.
  • On a year-over-year basis, Liabilities and Shareholders Equity has increased for 28 consecutive quarters, with growth averaging 49.7% over the last eight quarters.
  • Across the past five years, year-over-year growth in Liabilities and Shareholders Equity ran from 23.6% in Q4 2021 to 86.8% in Q3 2024.
  • Per Business Quant, the preceding three quarters came in at $1.1 billion (Q4 2025), $1.05 billion (Q3 2025) and $971.92 million (Q2 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 201.06 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 135.12 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 129.80 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 122.03 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 115.83 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 95.64 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 49.36 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 201.13 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 27.42 Bn
10 Catalyst Pharmaceuticals 3.85 Bn 1.04 Bn 134.92 Mn 1.15 Bn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 1.15 Bn
Dec 31, 2025 1.10 Bn
Sep 30, 2025 1.05 Bn
Jun 30, 2025 971.92 Mn
Mar 31, 2025 908.87 Mn
Dec 31, 2024 851.41 Mn
Sep 30, 2024 772.01 Mn
Jun 30, 2024 706.36 Mn
Mar 31, 2024 646.68 Mn
Dec 31, 2023 470.11 Mn
Sep 30, 2023 413.21 Mn
Jun 30, 2023 443.90 Mn
Mar 31, 2023 407.23 Mn
Dec 31, 2022 375.63 Mn
Sep 30, 2022 333.11 Mn
Jun 30, 2022 267.31 Mn
Mar 31, 2022 246.97 Mn
Dec 31, 2021 237.79 Mn
Sep 30, 2021 223.25 Mn
Jun 30, 2021 209.13 Mn
API Access

Catalyst Pharmaceuticals Liabilities and Shareholders Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=CPRX&period=max&api_key=YOUR_API_KEY